Silence Therapeutics plc (SLN, SLNCF)
CIK 1479615 · EDGAR correspondence
| Date | Company | Type | Outcome | Issues |
|---|---|---|---|---|
| 2026-01-09 | Silence Therapeutics plc (SLN, SLNCF) | SEC staff letter | Review completed (no further comments) | |
| 2025-12-31 | Silence Therapeutics plc (SLN, SLNCF) | Company response | Agreed to revise | R&D Expense Disclosure |
| 2025-12-18 | Silence Therapeutics plc (SLN, SLNCF) | SEC staff letter | 1 staff comment(s) issued | R&D Expense Disclosure |
Comments & responses
2025-12-18 · Form 10-K fo the fiscal year ended December 31, 2024 · Comment 1 · Research and Development Expenses, page 82 Agreed to revise
Staff comment: You disclose on page 79 that you have not historically tracked research and development expenses on a program-by-program basis for your preclinical product candidates. Please provide revised disclosure to be included in future filings to break out clinical research and development expense by program. If you do not track clinical costs by program, revise to disclose that fact and explain the reason. letter →
Company response: We have reviewed your letter requesting further disclosure of research and development expenses on a program-by-program basis for our development programs. As requested, we will further break out research and disclosure expenses on a program-by-program basis for our clinical development candidates. We will include this additional disclosure in Management’s Discussion and Analysis of Financial Condition and Results of Operation when we report our next Form 10-K for fiscal year ended December 31, 2025. response letter →
Templates & resources
- AICPA & CIMA – SEC reporting resources (AICPA & CIMA · Professional body · Free / member)
- BDO Accounting, Reporting & Compliance Hub (ARCH) (BDO · Firm guide · Free)
- Deloitte DART – Roadmap Series (Deloitte · Firm guide · Free)
- Deloitte Roadmap: SEC Comment Letter Considerations (Deloitte · Firm guide · Free)
- KPMG Financial Reporting View (KPMG · Firm guide · Free)
- PwC Viewpoint (PwC · Firm guide · Free / paid)
- RSM Financial Reporting Resource Center (RSM · Firm guide · Free)
- SEC – EDGAR Full Text Search (SEC · Regulator · Free)